AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 157 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.22 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $1,575,000 | -3.7% | 18,700 | -6.5% | 0.03% | +17.9% |
Q1 2018 | $1,635,000 | +697.6% | 20,000 | +455.6% | 0.03% | +833.3% |
Q4 2017 | $205,000 | -98.2% | 3,600 | -97.8% | 0.00% | -97.6% |
Q3 2017 | $11,120,000 | +364.9% | 166,600 | +258.3% | 0.13% | +252.8% |
Q2 2017 | $2,392,000 | -42.4% | 46,500 | -34.6% | 0.04% | -42.9% |
Q1 2017 | $4,152,000 | +90.4% | 71,100 | +72.2% | 0.06% | -12.5% |
Q3 2016 | $2,181,000 | +426.8% | 41,300 | +304.9% | 0.07% | +260.0% |
Q1 2016 | $414,000 | – | 10,200 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |